DCM
DRUG

Driehaus Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Driehaus Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4M Buy
433,377
+862
+0.2% +$67.7K 0.18% 176
2026
Q1 		$31.6M Buy
432,515
+162,874
+60% +$13.1M 0.23% 141
2025
Q4 		$21M Buy
+269,641
New +$18M 0.14% 200

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Driehaus Capital Management's DRUG Position: Q2 2026 in Review

Driehaus Capital Management increased its Bright Minds Biosciences (DRUG) stake by 0.2% in Q2 2026, buying an estimated $67.7K and bringing the position to 433,377 shares worth $30.4M. The position accounts for 0.18% of the portfolio, ranked #176.

Driehaus Capital Management first reported a position in DRUG in Q4 2025 and has held it in 3 quarters since. The position peaked at $31.6M in Q1 2026. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Driehaus Capital Management held 433,377 shares of Bright Minds Biosciences worth $30.4M as of Q2 2026.
  • Driehaus Capital Management bought 862 Bright Minds Biosciences shares in Q2 2026, an estimated $67.7K.
  • Bright Minds Biosciences made up 0.18% of Driehaus Capital Management's portfolio in Q2 2026, its #176 holding.
  • Driehaus Capital Management first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Driehaus Capital Management's Bright Minds Biosciences position peaked at $31.6M in Q1 2026.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.